Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmaceutical brand
|
| gptkbp:activeIngredient |
gptkb:acetylsalicylic_acid
|
| gptkbp:brand |
gptkb:aspirin
|
| gptkbp:contraindication |
asthma
peptic ulcer children with viral infections bleeding disorders |
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
gptkb:tablet
powder chewable tablet 325 mg 500 mg 81 mg suppository |
| https://www.w3.org/2000/01/rdf-schema#label |
Bayer Aspirin (U.S. rights)
|
| gptkbp:introducedIn |
1899
|
| gptkbp:legalStatus |
over-the-counter
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:owner |
gptkb:Bayer_AG
|
| gptkbp:productType |
gptkb:aspirin
|
| gptkbp:sideEffect |
gptkb:Reye's_syndrome_(in_children)
gastrointestinal bleeding allergic reaction |
| gptkbp:trademarkStatus |
registered trademark
|
| gptkbp:usedFor |
pain relief
anti-inflammatory blood thinning fever reduction |
| gptkbp:website |
https://www.bayeraspirin.com/
|
| gptkbp:bfsParent |
gptkb:Sterling_Drug
|
| gptkbp:bfsLayer |
7
|